Quetiapine to Reduce Post Concussive Syndrome After Mild Traumatic Brain Injury (mTBI)

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
A two site, 2‐arm, Phase III randomized pragmatic clinical trial evaluating theeffectiveness of quetiapine monotherapy in comparison to Treatment As Usual (TAU)medication management for symptoms experienced by veterans receiving rehabilitationtherapy for mild traumatic brain injury (mTBI) and comorbid symptoms of posttraumaticstress disorder (PTSD).
Epistemonikos ID: 31adc32efacc20236c3e84d375586fb7ffa19f7e
First added on: May 15, 2024